Targeted Treatment Trastuzumab is found to greatly Improve Long Term Survival of HER2 Breast Cancer Patients
The goal of this study is to assess the importance of adding adjuvant TRASTUZUMAB as a standard in her2 overexpressed breast cancer. Fifty female patients have known to be HER2 overexpressed breast cancer, recruited from the clinical oncology clinic at Beni-Suef University Hospital, and from the ins...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Beni-Suef University, Faculty of Medicine
2020-01-01
|
| Series: | Egyptian Journal of Medical Research |
| Subjects: | |
| Online Access: | https://ejmr.journals.ekb.eg/article_89043_9ab1075b69f36fe5062af32f53129aa2.pdf |